P3 Health Partners Inc.
جودة البيانات: 100%
KWD 2.64
▼
KWD 0.11
(-3.85%)
القيمة السوقية: 537.14 M
السعر
KWD 2.64
القيمة السوقية
537.14 M
نطاق اليوم
KWD 2.62 — KWD 2.77
نطاق 52 أسبوعًا
KWD 1.52 — KWD 11.30
حجم التداول
5,451
فتح KWD 2.77
متوسط 50 يوم / 200 يوم
KWD 2.47
6.94% above
متوسط 50 يوم / 200 يوم
KWD 5.68
53.43% below
Quick Summary
النقاط الرئيسية
Negative free cash flow of -122.87 M
Capital efficient — spends only 0.01% of revenue on capex
النمو
Revenue Growth (5Y)
N/A
Revenue (1Y)18.48%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-1016.92%
أقل من متوسط القطاع (-15.74%)
ROIC-82.75%
Net Margin-9.07%
Op. Margin-17.64%
الأمان
Debt / Equity
N/A
Current Ratio0.32
Interest Coverage-5.51
التقييم
PE (TTM)
-4.10
أقل من متوسط القطاع (-1.17)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Services (502 نظير)
مقارنة الأقران
مقابل وسيط قطاع Services (502 نظير)| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -4.1 | -1.2 |
| P/B | — | 1.4 |
| ROE % | -1016.9 | -15.7 |
| Net Margin % | -9.1 | -18.3 |
| Rev Growth 5Y % | — | 4.2 |
| D/E | — | 0.4 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 18.48% | Revenue Growth (3Y) | 405.31% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.44 B | Net Income (TTM) | -131.05 M |
| ROE | -1016.92% | ROA | -18.52% |
| Gross Margin | N/A | Operating Margin | -17.64% |
| Net Margin | -9.07% | Free Cash Flow (TTM) | -122.87 M |
| ROIC | -82.75% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.32 |
| Interest Coverage | -5.51 | Asset Turnover | 2.04 |
| Working Capital | -288.32 M | Tangible Book Value | -531.60 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -4.10 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | 0.37 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -22.87% | ||
| Market Cap | 537.14 M | Enterprise Value | 752.34 M |
| Per Share | |||
| EPS (Diluted TTM) | -22.62 | Revenue / Share | 7.11 |
| FCF / Share | -0.60 | OCF / Share | -0.60 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 0.01% | FCF Conversion | 93.76% |
| SBC-Adj. FCF | -129.31 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2024 | FY2023 | FY2021 | FY2022 |
|---|---|---|---|---|
| Revenue | 1.50 B | 1.27 B | 58.76 M | 1.05 B |
| Net Income | -135.85 M | -57.77 M | -10.08 M | -270.13 M |
| EPS (Diluted) | -1.08 | -0.63 | -0.24 | -6.50 |
| Gross Profit | — | — | — | — |
| Operating Income | -320.66 M | -167.93 M | -58.89 M | -1.56 B |
| EBITDA | — | — | — | — |
| R&D Expenses | — | — | — | — |
| SG&A Expenses | — | — | — | — |
| D&A | 86.06 M | 86.68 M | 187,558.0 | 87.29 M |
| Interest Expense | -22.17 M | -15.99 M | -1.32 M | -11.40 M |
| Income Tax | 4.39 M | 2.70 M | 0.0 | 1.86 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2024 | FY2023 | FY2021 | FY2022 |
|---|---|---|---|---|
| Total Assets | 783.42 M | 860.97 M | 2.36 B | 876.57 M |
| Total Liabilities | 633.89 M | 427.31 M | 299.94 M | 353.91 M |
| Shareholders' Equity | 75.94 M | 142.13 M | 273.55 M | 5.85 M |
| Total Debt | 89.82 M | 108.32 M | 83.62 M | 98.00 M |
| Cash & Equivalents | 38.82 M | 36.32 M | 140.48 M | 17.54 M |
| Current Assets | 184.14 M | 166.02 M | 199.86 M | 100.69 M |
| Current Liabilities | 496.42 M | 299.37 M | 198.77 M | 241.66 M |
{"event":"ticker_viewed","properties":{"ticker":"PIII","listing_kind":"stock","pathname":"/stocks/piii","exchange":"Nasdaq","country":"US"}}